QDEL - מכפיל P/S Quidel Corporation

QuidelOrtho (QDEL) is currently transforming its product portfolio to restore growth as it overcomes the decline in demand for COVID-19 tests. Revenues are based on the supply of analyzers and reagents for laboratories. The model scales through the sale of high-margin consumables. The price-to-sales ratio on this GURU.Markets chart shows that this metric remains around 0.30, helping to determine the fair value of the shares relative to revenue.

For the investor, this indicator serves as a tool to assess the premium paid for the QuidelOrtho (QDEL) business model, which is based on the scaling of the Sofia network and stable demand for consumables. By analyzing the price-to-sales ratio, you determine how many dollars of market capitalization the market is willing to pay per unit of revenue, allowing you to identify areas of overvaluation or undervaluation of the asset relative to its market expansion.